16 participants
CD8+ Antigen-Specific T Cells, Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Melanoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-10-08
- Start Date:
- 2015-01-22
- Completion:
- 2024-04-12
Conditions
- Metastatic Melanoma
- Stage IV Cutaneous Melanoma AJCC v6 and v7
Interventions
- BIOLOGICAL
- DRUG
- OTHER